m+Medelevator.RU
← Поиск публикаций
Zeitschrift fur Geburtshilfe und Neonatologie · 2026

[Significance of Early 75-g OGTT for the Detection of Glucose Disorders in High-Risk Women after Late Miscarriage or Preterm Birth].

Аннотация на английскомСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Markfeld Erol Filiz, Riedling Aaron, Juhasz-Böss Ingolf, Kunze Mirjam, Meschede Julia

Аннотация

INTRODUCTION: This study aimed to determine the proportion of pathological results in the early 75-g OGTT among women with a history of late miscarriage or preterm birth after prophylactic cerclage. The effects of early-diagnosed gestational diabetes on pregnancy outcome, neonatal parameters, preconceptional BMI, and mode of delivery were also analyzed.

METHODS: In 140 pregnant women, a primary cerclage and a 75-g OGTT were performed between 16 and 21 weeks of gestation. Analysis was based on OGTT results (physiological vs. pathological). The primary endpoint was pregnancy outcome; secondary endpoints included neonatal parameters, preconceptional BMI, and mode of delivery.

RESULTS: Eighty-nine women (63%) showed a pathological OGTT result substantially higher than in the general population. This was not significantly associated with late miscarriage or preterm birth (OR 2.18; p=0.13) but showed a trend toward increased risk. Neonatal outcomes were similar between groups. A preconceptional BMI>35 kg/m² was significantly related to a pathological OGTT (p=0.04). Women with a pathological OGTT had more cesarean deliveries (55.8% vs. 35.3%; p=0.02).

CONCLUSION: In this high-risk cohort with a history of late miscarriage or preterm birth, 63% had a pathological early 75-g OGTT, indicating increased susceptibility to glucose metabolism disorders. Early glucose screening and individualized metabolic management are essential to improve pregnancy and perinatal outcomes.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты